FDA Clears Abbott's High Sensitivity Troponin-I Blood Test
October 09, 2019
FDA Clears Abbott's High Sensitivity Troponin-I Blood Test
October 9, 2019 — Abbott recently announced that its Architect Stat High Sensitivity Troponin-I blood test has received…
Read More
FDA Grants Breakthrough Device Designation for Valiant Thoracoabdominal Aortic Aneurysm Stent Graft
October 09, 2019
FDA Grants Breakthrough Device Designation for Valiant Thoracoabdominal Aortic Aneurysm Stent Graft
October 9, 2019 — Medtronic plc announced it has received Breakthrough Device designation from the U.S. Food and Drug…
Read More
Medtronic is recalling the 6 French Sherpa NX Active Guide Catheter due to a risk of the outer material separating from the device resulting in detached fragments that could result in the underlying stainless-steel braid wires being exposed. These fragments could be left inside the patient’s bloodstream, and this or the attempts made to retrieve the fractured pieces, can cause other serious adverse health consequences such as continued blockage of blood vessels, injury to blood vessel walls, development of
October 09, 2019
Medtronic Recalls 6 French Sherpa NX Active Guide Catheters
October 9, 2019 — Medtronic is recalling the 6 French Sherpa NX Active Guide Catheter due to a risk of the outer…
Read More
American College of Cardiology Names Douglas Drachman Next Annual Scientific Session Vice Chair
October 08, 2019
American College of Cardiology Names Douglas Drachman Next Annual Scientific Session Vice Chair
October 8, 2019 — Douglas Drachman, M.D., FACC, has been selected as the next vice chair of the American College of…
Read More
PQ Bypass Granted IDE Approval to Start TORUS SFA Stent Graft Pivotal Study
October 08, 2019
PQ Bypass Granted IDE Approval to Start TORUS SFA Stent Graft Pivotal Study
October 8, 2019 — PQ Bypass Inc. announced it has received full approval of its investigational device exemption (IDE)…
Read More
The life of Afib patient Glynn Crawford was saved three days after being prescribed a Zoll LifeVest wearable defibrillator by his cardiologist Barbara Williams, M.D., at University Hospitals Ahuja Medical CenterShe identified him as a high-risk for sudden cardiac arrest.
October 07, 2019
Sudden Cardiac Arrest Patient Walks to Ambulance Thanks to Wearable Defibrillator
October 7, 2019 — Glynn Crawford was hospitalized at University Hospitals Ahuja Medical Center in late June/early July…
Read More
Heart MRI example. An example of a cardiac MRI exam showing perfusion defects in the heart muscle, amount of infarct and edema and a score for myocardial salvage which can help determine if revasularization will help restore heart function.
October 07, 2019
Cardiac MRI Delivers Accurate Diagnosis for Frontline Chest Pain Evaluation
October 7, 2019 – A recent study published in the New England Journal of Medicine supports the use of cardiac magnetic…
Read More
A Sapien 3 TAVR valve in position as seen under GE Assist guidance on angiography. Study Finds Sustained Benefit for TAVR vs. SAVR at One Year. #TCT2019 #TCT19
October 04, 2019
Study Finds Sustained Benefit for TAVR vs. SAVR at One Year
October 4, 2019 – A new analysis of the PARTNER 3 Trial data found a modest, but significant, improvement in one-year…
Read More
The COAPT Economic Analysis sub-study found it is cost effective to treat heart failure patients who have severe secondary mitral regurgitation with MitraClip to reduce their MR symptoms. #TMVR #TCT2019 #TCT19
October 04, 2019
Transcatheter Mitral Valve Repair is Cost-Effective in Heart Failure Patients
October 4, 2019 – Results of a new economic analysis of the COAPT Trial data found that transcatheter mitral valve…
Read More
RenalGuard Therapy was found to be superior to the POSEIDON method in preventing contrast-induced acute kidney injury (CI-AKI) for patients with kidney disease who undergo interventional cath lab procedures. Results of the 700 patient, randomized, investigator-driven REMEDIAL III Trial presented at the 2019 Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium. #TCT19 #TCT2019
October 04, 2019
Contrast-Induced Kidney Injury Prevented With RenalGuard in REMEDIAL III Trial
October 4, 2019 – RenalGuard Therapy was found to be superior to the POSEIDON method in preventing contrast-induced…
Read More
Five-year results from the PARTNER 2A Trial found patients with severe aortic stenosis (AS) and intermediate surgical risk who underwent Sapien 3 transcatheter aortic valve replacement (TAVR) had similar rates of death and disabling stroke compared to those who had surgical aortic valve replacement (SAVR). However, TAVR using a transthoracic approach had poorer outcomes compared to SAVR. #TCT2019
October 03, 2019
Similar Outcomes for TAVR vs. SAVR in Intermediate Surgical Risk Patients
October 3, 2019 – Five-year results from the PARTNER 2A Trial found patients with severe aortic stenosis (AS) and…
Read More
People watch the presentation of the five-year EXCEL Trial data by Gregg Stone, M.D., live in the Abbott booth at TCT 2019. Abbott makes the Xience stent used in the trial, which compared equally with long term surgical outcomes. #TCT2019
October 03, 2019
Left Main Treated With PCI or CABG Have Similar Outcomes at Five Years
October 3, 2019 – Five-year data from the EXCEL Trial showed patients with left main coronary disease treated with…
Read More
COAPT Trial three-year data show the MitraClip continued effectiveness in heart failure patients with secondary mitral reguritation. #TCT2019 #TCT19 #mitralclip
October 03, 2019
COAPT Three-year Data Show Continued Effectiveness in Heart Failure Patients
October 3, 2019 – The three-year results from the COAPT Trial demonstrated that reducing severe secondary mitral…
Read More
The Boston Scientiofic Acurate Neo TAVR valve did not meet non-inferiority to the Sapien 3 valve in patients with severe aortic stenosis. #TAVR #TCT2019
October 02, 2019
New Acurate neo Self-expanding TAVR Device Does Not Meet Non-Inferiority Compared to Sapien 3
October 2, 2019 – The first randomized trial to compare the safety and efficacy of the new Boston Scientific Acurate…
Read More
The Portico FDA investigational device exemption (IDE) study found that 30-day safety and one-year effectiveness outcomes of a novel self-expanding transcatheter aortic valve replacement (TAVR) system for patients with severe aortic stenosis (AS) at high or extreme-risk for surgery was noninferior to contemporary FDA-approved TAVR systems. #TAVR #TCT2019
October 02, 2019
Portico TAVR System Found Safe and Effective for High-Risk Surgical Patients
October 2, 2019 – The Abbott Portico FDA investigational device exemption (IDE) study found that 30-day safety and one-…
Read More
Two Stents Implanted in Democratic Presidential Candidate Bernie Sanders, suffers chest pain
Dave Fornell, Editor
October 02, 2019
Two Stents Implanted in Democratic Presidential Candidate Bernie Sanders
October 2, 2019 — Democratic presidential candidate Sen. Bernie Sanders (D-VT) was hospitalized with chest pain on Oct…
Read More
This is a view of the Level Ex IVUS training app to help users of Philips' intravascular ultrasound system. It is integrated into a percutenous coronary intervention (PCI) training app for mobile devices that allows interventional cardiologists to perform streamlined cath lab patient case simulations, including, iFR, angioplasty and stenting. #TCT2019
October 02, 2019
IVUS and iFR Video Game App Training Offered by Philips and Level Ex
October 2, 2019 — Philips Healthcare is utilizing Level Ex’s video game app design expertise to train interventional…
Read More
Comparison of a STEMI coronary artery blockage pre- and post-PCI for a patient who had a 9-minute door-to-balloon time at a rural hospital that implemented a pre-hospital STEMI protocol. This article was submitted by UH Portage Medical Center about how they set up their program.
Dave Fornell, Editor
October 01, 2019
Most Popular Cardiology Technology Content in September 2019
October 1, 2019 — Here is the list of the most popular content on the Diagnostic and Interventional Cardiology (DAIC)…
Read More
Khaldoon Alaswad, M.D., right, director, cardiac catheterization lab, during a complex CTO procedure at Henry Ford Hospital.
Dave Fornell, Editor
October 01, 2019
Innovations in Cardiology at Henry Ford Hospital
Henry Ford Hospital thought leaders regularly speak at the cardiology conferences about new research and technology…
Read More
Resolute Onyx Drug-Eluting Stent Noninferior to Polymer-Free Drug-Coated Stent With One-Month DAPT
September 30, 2019
Resolute Onyx Drug-Eluting Stent Noninferior to Polymer-Free Drug-Coated Stent With One-Month DAPT
September 30, 2019 – The first randomized trial to compare a durable polymer drug-eluting stent to a polymer-free drug-…
Read More
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now